utah semaglutide Poison Control Center sees 600% increase in calls from misuse of weight loss drugs Tirzepatide & Semaglutide Weight Loss

You can read the full article at Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial PMC (nih.gov)

Tirzepatide : Also targeting weight loss and glucose control, this medication acts on both GLP-1 and GIP receptors, potentially offering greater efficacy

But more importantly, XPOF is in the process of acquiring Lindora

If nausea, vomiting, or other side effects occur, communicate with your providerdose reduction or extended time at current level is often safer and effective

However, its important to note that while these GLP-1 receptor agonists are highly effective, they may not be suitable for everyone